Cent Eur J Public Health 2018, 26(4):247-252 | DOI: 10.21101/cejph.a5012

Evaluation of purified protein derivates test at tuberculosis dispensary in Hatay, Turkey, applied to Turks and Syrian refugees (2012-2015)

Nazan Savaş1, Gülnur Barutcu2, Arif Yeniçeri1
1 Department of Public Health, Medical Faculty, Mustafa Kemal University, Antakya, Hatay, Turkey
2 Hatay Merkez Tuberculosis Dispensary, Hatay Provincial Directorate of Public Health, Hatay, Turkey

Objective: The aim of the study was to evaluate results of purified protein derivates (PPD) test applied at the Tuberculosis Dispensary between 2012-2015 in Hatay, Turkey, where a large number of Syrian refugees have migrated since the Syrian civil war began in 2011.

Methods: PPD test records from the Electronic Tuberculosis Management System at the Tuberculosis Dispensary from 2012-2015 were analyzed based on nationality, age groups, BCG scar availability, and PPD reaction. The annual risk of tuberculosis infection (ARTI) was calculated based on years for each age group in Turks and Syrian refugees and the trend was evaluated. Student-t, Chi-square, and Mantel-Haenszel tests were used in statistical analyses, p < 0.05 was considered significant.

Results: In total, 5,255 PPD tests were made, 15.5% were Syrian refugees. BCG scar was missing in 48.5% of Turks and 87.3% of refugees (p < 0.001). The 0-5 age group represented the lowest rate (Turks 3.2%, refugees 4.3%) and the 19-64 age group represented the highest rate (Turks 51.1%, refugees 54.1%) of positive PPD reaction among individuals without BCG scar. Among individuals without BCG scar, more positive PPD reactions developed in refugees of the 6-18 group than in Turks (Turks 16.9%, refugees 46.4%, p < 0.001). Among individuals with BCG scar, more positive PPD reactions developed among refugees of the 0-5 (Turks 7.8%, refugees 24.0%, p = 0.049) and 19-64 (Turks 36.6%, refugees 58.8%, p = 0.028) age groups. ARTIs between 2012-2015 were 0.2%, 1.0%, 1.3%, and 1.4% among Turks, (except 2012) 2.3%, 0.3%, 2.4% among refugees in the 0-5 age group, 1.1%, 2.0%, 1.7%, and 1.5% among Turks, and 8.5%, 6.6%, 7.3%, and 2.4% among refugees in the 6-18 age group, respectively.

Conclusion: Higher positive PPD reactions and ARTIs were found among Syrian refugees, more specifically in the 6-18 age group.

Keywords: tuberculosis, Syrian refugee, Turkey

Received: December 14, 2016; Revised: November 2, 2018; Published: December 31, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Savaş N, Barutcu G, Yeniçeri A. Evaluation of purified protein derivates test at tuberculosis dispensary in Hatay, Turkey, applied to Turks and Syrian refugees (2012-2015). Cent Eur J Public Health. 2018;26(4):247-252. doi: 10.21101/cejph.a5012. PubMed PMID: 30660134.
Download citation

References

  1. World Health Organization. Global tuberculosis report 2015. Geneva: WHO; 2015.
  2. Getahun H, Matteelli A, Chaisson RE, Raviglione M. Latent Mycobacterium tuberculosis infection. N Eng J Med. 2015;372(22):2127-35. Go to original source... Go to PubMed...
  3. Borgdorff MW. Annual risk of tuberculosis infection-time for an update? Bull World Health Org. 2002;80(6):501-2.
  4. World Health Organization. Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization; 2015.
  5. Pai M, Denkinger CM, Kik SV, Rangaka MX, Zwerling A, Oxlade O, et al. Gamma interferon release assays for detection of Mycobacterium tuberculosis infection. Clin Microbiol Rev. 2014;27(1):3-20. Go to original source... Go to PubMed...
  6. Wang L, Turner MO, Elwood RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guérin vaccination on tuberculin skin test measurements. Thorax. 2002;57(9):804-9. Go to original source... Go to PubMed...
  7. Akdag R, editor. Tuberculosis diagnosis and treatment guidelines 2011. Ankara: Basak Matbaacilik ve Tanitim Hizmetleri; 2011. (In Turkish.)
  8. Republic of Turkey, Ministry of Health, Department of Tuberculosis. Reference book for the control of tuberculosis in Turkey. Ankara: Rekmay; 2003.
  9. Chee CB, Soh CH, Boudville IC, Chor SS, Wang YT. Interpretation of the tuberculin skin test in Mycobacterium bovis BCG-vaccinated Singaporean schoolchildren. Am J Respir Crit Care Med. 2001;164(6):958-61. Go to original source... Go to PubMed...
  10. Kritzinger FE, den Boon S, Verver S, Enarson DA, Lombard CJ, Borgdorff MW, et al. No decrease in annual risk of tuberculosis infection in endemic area in Cape Town, South Africa. Trop Med Int Health. 2009;14(2):136-42. Go to original source... Go to PubMed...
  11. Demir T. Epidemiology of tuberculosis. In: Tuberculosis Symposium in Adult and Child; 1999 Apr 30; Istanbul, Turkey. p. 9-13. (In Turkish.)
  12. Turkish Statistical Institute. Address Based Population Registration System. Hatay population 2015 [Internet]. [cited 2018 Nov 2]. Available from: https://biruni.tuik.gov.tr/medas/?kn=95&locale=tr. (In Turkish.)
  13. Population of Syrian refugees in Hatay [Internet]. [cited 2018 Nov 2]. Available from: http://www.haberler.com/hatay-valisi-topaca-1-5-milyon-nufuslu-kentimizde-8186628-haberi. (In Turkish.)
  14. Rieder H. Annual risk of infection with Mycobacterium tuberculosis. Eur Respir J. 2005;25(1):181-5. Go to original source... Go to PubMed...
  15. Garyfalia V, Irini G, Vasilios S, Konstantinos G. Annual risk of tuberculosis infection in hellenic air force recruits. Open Respir Med J. 2013;7:77-82. Go to original source... Go to PubMed...
  16. American Thoracic Society. Targeted tuberculin testing and treatment of latent tuberculosis infection. MMWR Recomm Rep. 2000 Jun 9;49(RR-6):1-51.
  17. Schluger NW. Advances in the diagnosis of latent tuberculosis infection. Semin Respir Crit Care Med. 2013;34(1):60-6. Go to original source... Go to PubMed...
  18. Herrera V, Perry S, Parsonnet J, Banaei N. Clinical application and limitations of interferon-gamma release assays for the diagnosis of latent tuberculosis infection. Clin Infect Dis. 2011;52(8):1031-7. Go to original source... Go to PubMed...
  19. Ghobarah HA, Huth P, Russett B. Civil wars kill and maim people-long after the shooting stops. Am Polit Sci Rev. 2003; 97(2):189-202. Go to original source...
  20. Doganay M, Demiraslan H. Refugees of the Syrian civil war: impact on reemerging infections, health services, and biosecurity in Turkey. Health Secur. 2016 Jul-Aug;14(4):220-5. Go to original source... Go to PubMed...
  21. Cookson ST, Abaza H, Clarke KR, Burton A, Sabrah NA, Rumman KA, et al. "Impact of and response to increased tuberculosis prevalence among Syrian refugees compared with Jordanian tuberculosis prevalence: case study of a tuberculosis public health strategy". Confl Health. 2015 May 18;9:18. doi: 10.1186/s13031-015-0044-7. Go to original source... Go to PubMed...
  22. Verbon A, Cobelens FG. Indications for, and the significance of, the tuberculin test in the Netherlands. Ned Tijdschr Geneeskd. 2003 Mar 22;147(12):539-43. (In Dutch.)
  23. UN News. Syria experiencing critical shortage in medicines - WHO [Internet]. UN; 2012 [cited 2018 Nov 2]. Available from: https://news.un.org/en/story/2012/08/417182-syria-experiencing-critical-shortage-medicines-who.
  24. Tuberculosis. In: Pickering LK, Baker CJ, Kimberlin DW, Long SS, editors. Red book: 2012 report of the Committee on Infectious Diseases. Elk Grove Village: American Academy of Pediatrics; 2012. p. 736-59.
  25. Gökçay G, Partalci A, Baş F, Neyzi O. Tuberculin reactivity in young children following neonatal BCG vaccination. J Trop Pediatr. 2000 Feb;46(1):51-2. Go to original source... Go to PubMed...
  26. Tuberculin skin test survey in a pediatric population with high BCG vaccination coverage - Botswana, 1996. MMWR Morb Mortal Wkly Rep. 1997 Sep 12;46(36):846-51.
  27. Huebner RE, Schein MF, Bass JB, Jr. The tuberculin skin test. Clin Infect Dis. 1993;17(6):968-75. Go to original source... Go to PubMed...
  28. Starke JR; Committee on Infectious Diseases. Interferon-gamma release assays for diagnosis of tuberculosis infection and disease in children. Pediatrics. 2014 Dec;134(6):e1763-73. Go to original source... Go to PubMed...
  29. Landry J, Menzies D. Preventive chemotherapy. Where has it got us? Where to go next? Int J Tuberc Lung Dis. 2008;12(12):1352-64. Go to PubMed...
  30. Beser E. The prevalence of pulmonary tuberculosis using different methods in group screenings. East Afr Med J. 1993;70(12):768-71.
  31. Shanaube K, Sismanidis C, Ayles H, Beyers N, Schaap A, Lawrence KA, et al. Annual risk of tuberculous infection using different methods in communities with a high prevalence of TB and HIV in Zambia and South Africa. PLoS One. 2009 Nov 13;4(11):e7749. doi: 10.1371/journal.pone.0007749. Go to original source... Go to PubMed...
  32. Styblo K. Epidemiology of tuberculosis. Sel Pap R Neth Tuberc Assoc. 1991;24:1-136.
  33. Cauthen GM, Pio A, ten Dam HG. Annual risk of tuberculous infection. WHO; 1988.
  34. Haghdoost AA, Afshari M, Baneshi MR, Gouya MM, Nasehi M, Movahednia M. Estimating the annual risk of tuberculosis infection and disease in southeast of Iran using the bayesian mixture method. Iran Red Crescent Med J. 2014 Sep 5;16(9):e15308. doi: 10.5812/ircmj.15308. Go to original source... Go to PubMed...
  35. Dubuis M, Fiekert K, Johnston M, Neuenschwander BE, Rieder HL. A tuberculin skin test survey among Afghan children in Kabul. Int J Tuberc Lung Dis. 2004;8(9):1065-72. Go to PubMed...
  36. Kolappan C, Gopi PG, Subramani R, Chadha VK, Kumar P, Prasad VV, et al. Estimation of annual risk of tuberculosis infection (ARTI) among children aged 1-9 years in the south zone of India. Int J Tuberc Lung Dis. 2004;8(4):418-23. Go to PubMed...